Country singerWynonna Juddhad a very exciting reason to celebrate on June 10, as she and h...
Shohei Ohtani threw his third live session against hitters today and, as Jack Harris of th...
US tariffs cast pall over green energy industry in Thailand, Cambodia, Vietnam and Malaysi...
Japan has become famous for sending weird and wacky acts to America’s Got Talent the past...
These are the key events on day 1,203 of Russia’s war on Ukraine.
Countries
Opinion
Lefty lawmakers’ war on cows is another senseless progressive beef with upstate farmers
The NY State Education Department’s self-damning war on the Massapequa Chiefs
Trust no one: The Pentagon needs to come clean about UFO lies
Trump's Military Base Renaming: Returning to Confederate Roots
Afghan refugee office is a corrupt failure — Trump is right to shut it down
- PR Newswire ( Middle East ) 2025/2/16
Revolutionising Vascular Access Care for Critically Ill Newborns and Children Key Points: FDA 510(k) Clearance Neonav® ECG Tip Location Syst...
- Devdiscourse ( Middle East ) 2025/2/16
In a sweeping effort to trim the federal workforce, the Trump administration has extended its reach to the Food and Drug Administration (FDA...
- News10NBC ( Middle East ) 2025/2/16
WASHINGTON (AP) — The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this...
- Independent ( Yemen ) 2025/2/16
The two-pound boxes of pancake mixe were recalled last month because they may have contained undeclared milk
- Variety ( Middle East ) 2025/2/15
In his early 20s, Norwegian director Halfdan Ullmann Tøndel held a variety of roles at a primary school, including substitute teaching, lead...
- Independent ( Yemen ) 2025/2/15
The recall was first issued in December because the granola bars ‘may contain a piece of metal’
- CBS News ( Middle East ) 2025/2/15
The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is an import...
- Medscape ( Middle East ) 2025/2/15
Vimseltinib is the second CSF1 receptor blocker to enter the US market for tenosynovial giant cell tumors. Medscape Medical News
- PR Newswire ( Middle East ) 2025/2/13
NORTHFIELD, Minn., Feb. 13, 2025 /PRNewswire/ -- Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approve...
- Medscape ( Middle East ) 2025/2/12
Adding brentuximab vedotin to lenalidomide and rituximab significantly reduced the risk for death by 37% in the randomized, placebo-controll...
- PR Newswire ( Middle East ) 2025/2/12
The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multipl...
- PR Newswire ( Middle East ) 2025/2/12
VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced techno...
- Medscape ( Middle East ) 2025/2/12
The kinase inhibitor is now approved for adults and children aged ≥ 2 years with neurofibromatosis type 1 who have unresectable symptomatic...
- CBS News ( Middle East ) 2025/2/11
The NGO Doctors for America argued that HHS, CDC and FDA violated federal law in removing medical information from public-facing websites.